By Ben Glickman
Shares of Renovaro Biosciences rose Tuesday after the company appointed two finance industry veterans to its board.
The stock was up 15% to $5.01 in afternoon trading. Shares have more than quadrupled this year.
The Los Angeles-based biotechnology firm said Leni Boeren and Ruud Hendriks would join the board as independent directors ahead of the proposed combination with artificial intelligence company GEDi Cube.
Renovaro said Boeren held positions at Paribas, Rabobank, Amsterdam Exchanges and Euronext, in addition to working in asset management as chief executive and chair of Robeco Groep. She has had a 40-year career in the financial sector.
Hendriks has worked at Goldman Sachs Asset Management and Robeco and as an adviser to private-equity firm KKR over a 35-year career.
“Their substantial experience in the capital markets and asset management will bring invaluable financial and business expertise as we advance towards commercialization,” Renovaro Chairman Rene Sindlev said.
Write to Ben Glickman at [email protected]
Read the full article here
